Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent M&A activity – licensing and alliances are covered in a separate column (see sidebar). Deal Watch is supported by deal intelligence from Strategic Transactions.
Slated since inception to perhaps be acquired by Sanofi, the computational drug discovery biotech Warp Drive Bio Inc.instead was annexed by Revolution Medicines Inc. in a stock transaction announced Oct. 16